CS240997B2 - Production method of n-(3-trifluormethylphenyl)-n-propargylpiperazine - Google Patents
Production method of n-(3-trifluormethylphenyl)-n-propargylpiperazine Download PDFInfo
- Publication number
- CS240997B2 CS240997B2 CS841274A CS127484A CS240997B2 CS 240997 B2 CS240997 B2 CS 240997B2 CS 841274 A CS841274 A CS 841274A CS 127484 A CS127484 A CS 127484A CS 240997 B2 CS240997 B2 CS 240997B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- trifluoromethylphenyl
- propargylpiperazine
- formula
- compound
- acid addition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833306964 DE3306964A1 (de) | 1983-02-28 | 1983-02-28 | Neues n-arylpiperazin und verfahren zu seiner herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS127484A2 CS127484A2 (en) | 1985-06-13 |
| CS240997B2 true CS240997B2 (en) | 1986-03-13 |
Family
ID=6192038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS841274A CS240997B2 (en) | 1983-02-28 | 1984-02-23 | Production method of n-(3-trifluormethylphenyl)-n-propargylpiperazine |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4699910A (fr) |
| EP (1) | EP0117531B1 (fr) |
| JP (1) | JPS59210074A (fr) |
| KR (1) | KR910005413B1 (fr) |
| AT (1) | ATE22289T1 (fr) |
| AU (1) | AU562643B2 (fr) |
| CA (1) | CA1240327A (fr) |
| CS (1) | CS240997B2 (fr) |
| DD (1) | DD218096A5 (fr) |
| DE (2) | DE3306964A1 (fr) |
| DK (1) | DK158729C (fr) |
| ES (7) | ES530073A0 (fr) |
| FI (1) | FI77658C (fr) |
| GB (1) | GB2135997B (fr) |
| GR (1) | GR79822B (fr) |
| HU (1) | HU190546B (fr) |
| IE (1) | IE56938B1 (fr) |
| IL (1) | IL71068A (fr) |
| NO (1) | NO158803C (fr) |
| NZ (1) | NZ207289A (fr) |
| PH (1) | PH21982A (fr) |
| PL (1) | PL141275B1 (fr) |
| PT (1) | PT78155B (fr) |
| SU (1) | SU1223844A3 (fr) |
| ZA (1) | ZA841418B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03176457A (ja) * | 1989-12-04 | 1991-07-31 | Nippon Paint Co Ltd | 新規プロパルギル化合物、その製法ならびに該化合物を含む被覆材 |
| JPH05255089A (ja) * | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | 抗ウイルス剤 |
| US5661163A (en) | 1995-06-07 | 1997-08-26 | Merck & Co., Inc. | Alpha-1a adrenergic receptor antagonists |
| USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
| EA027748B1 (ru) | 2012-04-04 | 2017-08-31 | Тева Фармасьютикалз Интернэшнл Гмбх | Применение придопидина в комбинации с тетрабеназином для лечения двигательных нарушений и ожирения |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2993899A (en) * | 1958-03-31 | 1961-07-25 | Miles Lab | Acetylenically unsaturated piperazine derivatives |
| NL6607959A (fr) * | 1965-06-10 | 1966-12-12 | ||
| DE1545561A1 (de) * | 1965-08-23 | 1969-12-11 | Acraf | Verfahren zur Herstellung von pharmakologisch aktiven N,N-disubstituierten 1-Aryl-3-aminopropinen |
| FR2187311B1 (fr) * | 1972-06-02 | 1975-06-20 | Bouchara Emile | |
| GB1560271A (en) * | 1977-01-14 | 1980-02-06 | Joullie International Sa | Therapeutically useful m-trifluoromethylphenylpiperazine derivatives |
| US4180574A (en) * | 1978-12-26 | 1979-12-25 | Abbott Laboratories | Certain ovicidal piperazines |
| US4518712A (en) * | 1980-06-30 | 1985-05-21 | Taiho Pharmaceutical Company Limited | Piperazine derivative and analgesic composition containing the same |
-
1983
- 1983-02-28 DE DE19833306964 patent/DE3306964A1/de not_active Withdrawn
-
1984
- 1984-02-23 CS CS841274A patent/CS240997B2/cs unknown
- 1984-02-23 EP EP84101894A patent/EP0117531B1/fr not_active Expired
- 1984-02-23 FI FI840743A patent/FI77658C/fi not_active IP Right Cessation
- 1984-02-23 AT AT84101894T patent/ATE22289T1/de active
- 1984-02-23 GR GR73907A patent/GR79822B/el unknown
- 1984-02-23 DE DE8484101894T patent/DE3460733D1/de not_active Expired
- 1984-02-24 DD DD84260319A patent/DD218096A5/de not_active IP Right Cessation
- 1984-02-24 DK DK102084A patent/DK158729C/da not_active IP Right Cessation
- 1984-02-27 ZA ZA841418A patent/ZA841418B/xx unknown
- 1984-02-27 NO NO840732A patent/NO158803C/no unknown
- 1984-02-27 JP JP59035872A patent/JPS59210074A/ja active Granted
- 1984-02-27 IE IE460/84A patent/IE56938B1/en not_active IP Right Cessation
- 1984-02-27 SU SU843706206A patent/SU1223844A3/ru active
- 1984-02-27 CA CA000448370A patent/CA1240327A/fr not_active Expired
- 1984-02-27 NZ NZ207289A patent/NZ207289A/en unknown
- 1984-02-27 PT PT78155A patent/PT78155B/pt not_active IP Right Cessation
- 1984-02-27 PL PL1984246418A patent/PL141275B1/pl unknown
- 1984-02-27 HU HU84771A patent/HU190546B/hu not_active IP Right Cessation
- 1984-02-27 ES ES530073A patent/ES530073A0/es active Granted
- 1984-02-27 PH PH30304A patent/PH21982A/en unknown
- 1984-02-27 AU AU25085/84A patent/AU562643B2/en not_active Ceased
- 1984-02-27 IL IL71068A patent/IL71068A/xx unknown
- 1984-02-28 KR KR1019840000990A patent/KR910005413B1/ko not_active IP Right Cessation
- 1984-02-28 GB GB08405113A patent/GB2135997B/en not_active Expired
- 1984-10-01 ES ES536411A patent/ES536411A0/es active Granted
- 1984-10-01 ES ES536413A patent/ES536413A0/es active Granted
- 1984-10-01 ES ES536414A patent/ES536414A0/es active Granted
- 1984-10-01 ES ES536412A patent/ES536412A0/es active Granted
- 1984-10-01 ES ES536415A patent/ES536415A0/es active Granted
- 1984-10-01 ES ES536416A patent/ES536416A0/es active Granted
-
1985
- 1985-11-22 US US06/800,525 patent/US4699910A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4042700A (en) | Quaternary N-β-substituted N-alkyl-nortropine benzilates | |
| KR100543614B1 (ko) | 4-페닐피페리딘 화합물 | |
| US6306904B1 (en) | Antihistaminic/antitussive compositions | |
| US7273623B2 (en) | Process for preparing tannate tablet, capsule or other solid dosage forms | |
| JP2008509953A (ja) | ４−［［（７ｒ）−８−シクロペンチル−７−エチル−５，６，７，８−テトラヒドロ−５−メチル−４−６−オキソ−２−ピペリジニル］アミノ］−３−メトキシ−ｎ−（１−メチル−４−ピペリジニル）ベンズアミドの水和物及び多形、その製造方法、並びにその薬物としての使用 | |
| DE3827727A1 (de) | Anellierte tetrahydropyridinessigsaeurederivate, verfahren zu deren herstellung und verwendung solcher verbindungen zur kardioprotektion | |
| ES2280607T3 (es) | Medicamento neuroprotector. | |
| JPS6156227B2 (fr) | ||
| CS240997B2 (en) | Production method of n-(3-trifluormethylphenyl)-n-propargylpiperazine | |
| US20040266790A1 (en) | Risperidone monohydrochloride | |
| US2918406A (en) | Anti-spasmodics specific for peptic ulcer | |
| DE69215482T2 (de) | 2,2'-Alkylendiindolderivate, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung als Ulcustherapeutikum | |
| HU198454B (en) | Process for production of new derivatives of tetrahydrospiridin and medical compositions containing these compounds | |
| CZ20014458A3 (cs) | Polymorfní formy krystalického (2-benzhydryl-l-azabicyklo[2,2,2]okt-3-yl)-(5-isopropyl-2-methoxybenzyl) amoniumchloridu jako antagonisté receptoru NK-1 | |
| EP0040947B1 (fr) | Utilisation de guanidines pour la fabrication de medicaments antidiarrhéiques et compositions antidiarrhéiques contenant ces dernières | |
| JPS6257606B2 (fr) | ||
| US20050069584A1 (en) | Diphenhydramine tannate solid dose compositions and methods of use | |
| DK170234B1 (da) | Hydrochloridhydrat af Endo-4-amino-5-chlor-2-methoxy-N-(1'-azabicyclo-[3.3.1]-non-4'-yl)-benzamid, fremgangsmåde til fremstilling deraf, farmaceutisk præparat indeholdende forbindelsen samt anvendelse af forbindelsen | |
| JPS6334865B2 (fr) | ||
| US6566396B2 (en) | Antitussive/antihistaminic compositions | |
| JPS588385B2 (ja) | コウウツビヨウカツセイオユウスル カゴウブツノセイゾウホウ | |
| US3377245A (en) | Methods and compositions for treating hypertension | |
| EP0140492B1 (fr) | Isoxicamate de L-arginine | |
| KR800001144B1 (ko) | 2-(4-페닐-4-시아노부틸)-1,2,3,4-테트라하이드로-5(H)-피리도-[4,3-b]-인돌의 제조방법 | |
| US4021576A (en) | Pharmaceutical compositions containing a 1-(2'-ethynyl-phenoxy)-2-hydroxy-3-(cycloalkyl-amino)-propane and method of use |